Why the study?
Do magnetic resonance techniques accurately monitor disease evolution and treatment trial outcomes in multiple sclerosis?
Do magnetic resonance techniques accurately monitor disease evolution and treatment trial outcomes in multiple sclerosis?
Magnetic resonance imaging techniques are sensitive and reliable for monitoring multiple sclerosis activity, with newer techniques offering potential for improved disease burden estimation in clinical trials.
Supports MRI monitoring in MS practice; leaves open validation of novel techniques as trial endpoints.
Although the correlations between magnetic resonance findings and long-term disease evolution range from poor to moderate, conventional precontrast and postcontrast magnetic resonance imaging provides sensitive and reliable measures to monitor multiple sclerosis activity over time. New pulse sequences with shorter acquisition times can be cost effective and reduce patients' discomfort. The application of other techniques that give more accurate estimates of disease burden and have higher pathological specificity might improve our understanding of multiple sclerosis evolution and provide new outcomes for monitoring clinical trials. Work is still needed to obtain optimal imaging of the spinal cord for multiple sclerosis diagnosis and monitoring.
No takes yet. Share an insight, caveat, or question.
Rovaris et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: